
The Ministry of HEALTH of RUSSIA has registered a drug for the treatment of CORONAVIRUS MIR 19, developed by the Federal Medical and Biological Agency, RBC was told in the press service of the department.
“The Ministry of Health of Russia has registered a drug for the treatment of coronavirus infection MIR 19,” the press service said. The drug was developed by the Federal State Budgetary Institution "SSC Institute of Immunology" of the Federal Medical and Biological Agency of Russia.
The Ministry of Health added that the effectiveness of the drug was studied in the red zone of hospitals in patients with moderate severity of COVID-19. The drug showed effectiveness in comparison with standard therapy, the department noted.
The HEAD of the FMBA called the drug "Mir-19" universal for all strains of covid Society
As the head of the FMBA Veronika Skvortsova said on the Russia 24 channel, studies have shown that a decrease in the viral load of patients with coronavirus is noticeable after the first use of the drug.